SRIVARU Holding Limited Secures Nasdaq Panel Approval for Continued Listing Amid Compliance Efforts
GRAND CAYMAN, Cayman Islands, Sept. 19, 2024 (GLOBE NEWSWIRE) — SRIVARU Holding Limited (Nasdaq: SVMH, SVMHW) (“SRIVARU” or the “Company”), […]
TSX News -
Proxy Advisor Glass, Lewis & Co., Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi
TORONTO, Ontario, Sept. 19, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce […]
Associated Capital Group, Inc. Announces Special Dividend of $2 Per Share
GREENWICH, Conn., Sept. 19, 2024 (GLOBE NEWSWIRE) — Associated Capital Group, Inc. (“AC” or the “Company”) (NYSE:AC), today announced that […]
CMC Metals Ltd. Completes A Significant Reclamation Program and Discovers Three Manto Zones at its Silver Hart Project, Yukon, Canada
VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) — CMC Metals Ltd. (TSX-V: CMB) (Frankfurt:ZM5P) (“CMC” or the “Company”) is […]
Ressources Cerro de Pasco annonce les résultats de son assemblée annuelle, la nomination d’une consultante et l’octroi d’options
MONTRÉAL, 19 sept. 2024 (GLOBE NEWSWIRE) — Ressources Cerro de Pasco Inc. (CSE: CDPR) (Frankfurt: N8HP) (« CDPR » ou […]
Cerro de Pasco Resources Announces AGM Results, Appointment of Consultant and Stock Options Grant
MONTREAL, Sept. 19, 2024 (GLOBE NEWSWIRE) — Cerro de Pasco Resources Inc. (CSE: CDPR) (Frankfurt: N8HP) (“CDPR,” or the “Corporation”) […]
IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology
Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader […]
Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th
Bright Minds Biosciences announced the initiation of Phase 2 clinical trial of BMB-101 in a group of drug-resistant epilepsies and […]
FibroBiologics Engages Southern Star Research as CRO in Australia
HOUSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued […]
Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board
Dr. Comenzo was the senior author of the landmark Andromeda trial results published in the New England Journal of Medicine […]
